TOKYO -- SBI Holdings launched a $40 million fund with contract drugmaker Shin Nippon Biomedical Laboratories this month for North American startups in biotechnology, drug discovery and artificial intelligence, looking for promising targets and new investment opportunities.
Startups
Japan's SBI kicks off $40m North America startup fund
Targets will cover fields like biotechnology, drug discovery and AI
SBI Holdings has a track record in forming and managing funds in Silicon Valley. (Photo by Tokuyuki Matsubuchi)
Read Next
.jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
Latest on Startups
